Taysha Gene Therapies, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of TSHA for the last quarter is 1.11 M USD, and it's 67.40% lower compared to the previous quarter. The net income of Q2 24 is -20.93 M USD.